Promising Vaccine Therapy for Glioblastoma Brain Cancers Moves on to Larger, Multisite Study
Phase II clinical trial will assess efficacy of Roswell Park-developed immunotherapy in newly diagnosed patients BUFFALO, N.Y. — An innovative vaccine therapy developed at Roswell Park Cancer Institute (RPCI) is being tested in...
Read More
